Stem cell agency lists own board members with conflicts of interest
By David Jensen,
Capitol Weekly
| 08. 24. 2022
In a first in its 18-year history, the California stem cell agency has begun posting on its website a list of its governing board members who have conflicts of interest as they award hundreds of millions of dollars.
The most recent example comes next Tuesday in a $48 million round that will benefit at least 16 public and private colleges in the Golden State and up to 400 students at a cost of $58,220 each.
The latest list shows that 25 members of CIRM’s 35-member governing board have conflicts in the round to be considered Tuesday.
The public conflict postings reflect an awareness of the need for transparency at the $12 billion agency, officially known as the California Institute for Regenerative Medicine (CIRM). The research effort was created by voters in 2004 via a ballot initiative, Proposition 71. The measure gave many of the potential beneficiaries a seat at the table where the money is handed out.
Since CIRM’s inception, about 80 percent of its awards — now totaling $3 billion — have gone to institutions that have...
Related Articles
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Sarah Kliff and Azeen Ghorayshi, The New York Times | 07.15.2024
By Katie LaGrone, WPTV | 06.28.2024
Image by National Cancer Institute from Unsplash
TAMPA, Fla. — A Tampa jury recently found the now-defunct Lung Institute in Tampa guilty of engaging in “deceptive or unfair practices” while it offered customers “valueless” stem cell therapy to treat incurable...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...